Three major effects of APOEε4 on Aβ immunotherapy induced ARIA
The targeting of amyloid-beta (Aβ) plaques therapeutically as one of the primary causes of Alzheimer’s disease (AD) dementia has been an ongoing effort spanning decades. While some antibodies are extremely promising and have been moved out of clinical trials and into the clinic, most of these treatm...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2024-05-01
|
| Series: | Frontiers in Aging Neuroscience |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fnagi.2024.1412006/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|